|Home | About | Journals | Submit | Contact Us | Français|
Crohn's disease is common in developed nations where the typical diet is low in fibre and high in processed food. Primary lesions overlie Peyer's patches and colonic lymphoid follicles where bacterial invasion through M-cells occurs. We have assessed the effect of soluble non-starch polysaccharide (NSP) and food emulsifiers on translocation of Escherichia coli across M-cells.
To assess effects of soluble plant fibres and food emulsifiers on translocation of mucosa-associated E coli isolates from Crohn's disease patients and from non-Crohn's controls, we used M-cell monolayers, generated by co-culture of Caco2-cl1 and Raji B cells, and human Peyer's patches mounted in Ussing chambers.
E coli translocation increased across M-cells compared to parent Caco2-cl1 monocultures; 15.8-fold (IQR 6.2–32.0) for Crohn's disease E coli (N=8) and 6.7-fold (IQR 3.7–21.0) for control isolates (N=5). Electron microscopy confirmed E coli within M-cells. Plantain and broccoli NSP markedly reduced E coli translocation across M-cells at 5 mg/ml (range 45.3–82.6% inhibition, p<0.01); apple and leek NSP had no significant effect. Polysorbate-80, 0.01% vol/vol, increased E coli translocation through Caco2-cl1 monolayers 59-fold (p<0.05) and, at higher concentrations, increased translocation across M-cells. Similarly, E coli translocation across human Peyer's patches was reduced 45±7% by soluble plantain NSP (5 mg/ml) and increased 2-fold by polysorbate-80 (0.1% vol/vol).
Translocation of E coli across M-cells is reduced by soluble plant fibres, particularly plantain and broccoli, but increased by the emulsifier Polysorbate-80. These effects occur at relevant concentrations and may contribute to the impact of dietary factors on Crohn's disease pathogenesis.
Crohn's disease results from an interaction between genetic and environmental factors. The genetic factors include changes in genes that affect handling of bacteria by the innate immune system, regulation of the immune response, or the mucosal barrier1 but the environmental factors, aside from smoking,2 are poorly understood. There are marked geographical variations in Crohn's incidence, with lower prevalence in underdeveloped countries, and a rapid recent rise in Japan that has parallelled the introduction of a ‘Western diet’.3 Moreover, clinical remission can be achieved by dietary interventions such as the use of specialised enteral feeds.4 It is therefore a plausible hypothesis that dietary factors may have either harmful or protective roles in Crohn's pathogenesis as a consequence of their effects on the interaction between the host epithelia and intestinal microbiota.
Increased numbers of E coli have been found in association with Crohn's mucosa by several independent groups.5 They have also been found in association with colorectal cancer.6 7 Many of the isolated strains associated with Crohn's disease fit the new pathovar designated adherent, invasive E coli (AIEC),8 as defined by their ability to adhere to, and invade intestinal epithelial cell lines in vitro (eg, I-407 and Caco2),6 9 and to survive and replicate intracellularly within macrophages without inducing host cell death.10 11 Crohn's E coli also cause interleukin 8 (IL-8) release from intestinal epithelial cells,12 and induce granuloma formation after internalisation by cultured macrophages.13 Despite considerable evidence of the presence of E coli within Crohn's tissue, particularly within macrophages and giant cells,14 15 they have not been shown within the intestinal epithelial cells. The early aphthoid lesions of Crohn's usually overlie Peyer's patches (PP) in the distal small intestine and the equivalent but smaller lymphoid follicles in the colon.16 17 The ‘dome’ epithelium that overlies PP and lymphoid follicles, also denoted follicle-associated epithelium (FAE), is the location of ‘membranous’ or ‘microfold’ cells (M-cells),18 specialised epithelial cells that account for about 5–10% of the FAE. They internalise macromolecules and microorganisms, and deliver them to the underlying lymphoid tissue, providing a portal from which an immune response can be mounted.19 They also serve as a portal of entry for bona fide pathogens, such as Mycobacteria,20 Listeria, Salmonella, Shigella21 and Vibrio cholerae.22 23 Since the initial lesions observed in Crohn's occur at PP and lymphoid follicles it seems likely that Crohn's mucosa-associated E coli, like Salmonella and Shigella, are translocated by M-cells and subsequently delivered to the underlying macrophages.
We have previously shown that the adhesion to, and invasion by Crohn's and colon cancer mucosa-associated E coli of, intestinal epithelial cells is inhibited by soluble plantain (green banana) fibre at concentrations that are potentially achievable in vivo.6 It is interesting that parts of the world such as Africa, India and Central America where plantains form an important part of the staple diet have low rates for inflammatory bowel disease and colon cancer. We have therefore now tested the ability of soluble plant fibres, such as those found in plantain, to block translocation of Crohn's E coli across M-cells in vitro.
Intestinal permeability is increased in patients with Crohn's disease and in their unaffected relatives. Although some of this increased permeability may be genetically determined it is also possible that environmental factors may be involved.24 The increase in the incidence of Crohn's disease seen in recent years in Japan correlates with increased fat intake.25 Although the fat itself may be harmful, it is also possible that increased consumption of emulsifiers contained in processed fatty foods could be a factor. Emulsifiers are detergents and, although permitted food emulsifiers are probably largely broken down during the digestive process, there has been relatively little investigation of their possible effects on intestinal permeability although it is well recognised that natural detergents in the form of bile acids can increase intestinal permeability26 and non-ionic detergents have been shown to increase permeability across Caco2 intestinal epithelial cell monolayers.27
In this study, Crohn's mucosa-associated E coli are shown to be translocated across Caco2-cl1-derived M-cells to a much greater extent than across monolayers formed from parent Caco2-cl1 cells, which was also confirmed in ex vivo human ileum tissues of FAE and villus epithelium (VE), respectively. Transcellular translocation was confirmed by transmission electron microscopy (TEM) in M-cells, but could not be observed in Caco2-cl1 cell monolayers. Translocation is inhibited by the presence of soluble plant fibres, including plantain and broccoli. Polysorbate-80, at concentrations that might occur in the distal ileum if 7% of ingested polysorbate survives digestion, causes increased translocation across parent Caco2-cl1 cells but not across M-cells.
E coli included strains previously isolated from colonic mucosal biopsies of six patients with Crohn's disease (HM95, HM154, HM413, HM419, HM580, HM605 and HM615)6 and the adherent, invasive ileal Crohn's strain, LF82.9 All our Crohn's colonic isolates were shown to meet current criteria for designation as AIEC.8 Five E coli from patients without Crohn's disease were included as controls (HM454 and HM456, both from a patient with sporadic polyposis; HM463 from a patient with haemorrhoids; HM484 and HM488, both from patients with irritable bowel syndrome,6 along with non-pathogenic E coli reference strains K12, XL-1blue and probiotic Nissle 1917. Salmonella typhimurium LT2 and Shigella sonnei were obtained from Dr Craig Winstanley, School of Infection & Host Defence, University of Liverpool).
Isolates were cultured on Luria–Bertani (LB) agar with overnight incubation in air at 37°C. Prior to infection of cultured epithelial cells, bacteria were washed three times, re-suspended in sterile phosphate-buffered saline (PBS) and adjusted to an OD550nm of 0.825 (equating to 1×109 CFU/ml).
Crohn's E coli HM615, selected due to its sensitivity to ampicillin and possession of adherent, invasive characteristics, was transformed with a plasmid carrying the enhanced green fluorescent protein (egfp) gene (pEGFP; BD Biosciences-Clontech, Mountain View, USA), without alteration of strain-specific characteristics,6 11 12 and was used in experiments examining bacterial translocation across ex vivo human FAE and VE.
Non-starch polysaccharide (NSP) preparations from plant-based soluble dietary fibre were provided by Provexis Plc (Windsor, UK). Plantain, the banana family (Musa) member that is usually cooked as a vegetable, was selected as it had previously been found to inhibit mucosa-associated E coli adhesion to epithelial cells in vitro.6 Plantain NSP consists of a complex mix of carbohydrates (see Supplementary document S1). Concentrations were chosen based on preliminary studies of inhibition of bacterial haemagglutination, inhibition of attachment to, and invasion of intestinal cells,6 and were within the range of intraluminal concentrations that would be readily achievable with dietary supplementation.
In addition, broccoli, leek and apple were selected to represent a range of common monocotyledon and dicotyledon sources of dietary soluble fibre. Common food emulsifiers used in the processed food industry, polysorbate-60 and polysorbate-80, were obtained from Sigma-Aldrich (Poole, UK). Polysorbate-80, has been shown to integrate within cell membranes,28 altering their microviscosity.29
The human colorectal adenocarcinoma cell-line Caco2-cl1 kindly provided by Dr Elisabet Gullberg (University Hospital Linköping, Sweden) was originally obtained from Dr Maria Rescigno (European Institute of Oncology, Milan, Italy).30 Caco2-cl1 were grown and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% vol/vol fetal bovine serum (FBS), 4 mM l-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. The human Burkitt's lymphoma cell-line Raji B (ECACC 85011429), obtained from the European Collection of Animal Cell Culture (Public Health Laboratory Service; Wiltshire, UK), was maintained in RPMI-1640 medium supplemented with 10% FBS, 8 mM l-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. Raji B cells were seeded at 3×105/ml and every third day cell suspensions were allowed to settle: Two thirds of the media was replaced with fresh culture media. Every ninth day, cells were split 1:3.
All cells were maintained at 37°C with 5% CO2 in a humidified atmosphere. Culture medium and supplements were supplied by Sigma-Aldrich excepting FBS (Invitrogen; Paisley, UK).
The apical face of 12 mm Transwell cell culture inserts with a polycarbonate membrane (Millicell-PCF 3 μm pore size; Millipore Ltd; Watford, UK) were each coated with 15 μg Matrigel basement membrane matrix (in 300 μl ice-cold DMEM without phenol red) per membrane. Coated membranes were left to gel for 1 h at room temperature in a sterile environment, followed by two 0.5 ml washes in DMEM without supplements. Caco2-cl1 were passaged, re-suspended in supplemented DMEM and 5×105 cells added to each Transwell (apical side). Supplemented DMEM (2 ml) was added to each basal compartment. Importantly, the apical medium was changed every day and the basal media on every other day. Cells were maintained for 14–18 days, until the trans-epithelial electrical resistance (TEER), measured using an EVOM epithelial voltohmmeter (World Precision Instruments, Stevenage, UK), was in excess of 600 Ω per Transwell (equivalent to 300 Ω cm2 tissue monolayer). On the day of co-culture, Raji B cells were harvested, re-suspended in complete DMEM and 5×105 cells added to the basal Transwell compartment. Importantly, following co-culture, both the apical and basal media were changed each day, with care being taken not to disturb the Raji B cells. Co-cultures were maintained for 4–6 days, until M-cells were generated. Parallel Caco2-cl1 monocultures (without Raji B cells in the basal compartment) were also generated on Transwell inserts and maintained as per M-cells. TEER was measured throughout to monitor successful monolayer generation. Translocation of Salmonella and Shigella was used to confirm successful generation of M-cells in vitro.
For all M-cell and Caco2-cl1 monoculture translocation experiments, DMEM medium was prepared with 10% FBS and 4 mM l-glutamine only (ie, without anti-microbial agents). Confluent monolayers were infected (from 0–4 h) with 1×107 E coli (a multiplicity of infection (MOI) 10:1) applied to the apical Transwell compartment (filter area 0.6 cm2). After infection, the basolateral medium was harvested and bacteria enumerated following overnight culture on LB agar plates incubated at 37°C in air. Colony forming units (CFU) of viable bacteria were quantified and data expressed as translocated CFU per cm2 filter.
For studies examining the effect of soluble dietary fibres, fresh DMEM (0.5 ml) containing 0–50 mg/ml NSP, either from apple, broccoli, leek or plantain, was applied to the apical aspect of the cells for 30 min at 37°C. Two millilitres of fresh DMEM was placed in the basolateral compartment. Cell monolayers were then infected with 1×107 E coli applied to the apical Transwell compartment. After 4 h, the basolateral medium was harvested and translocated bacteria quantified as described above.
For studies examining the effect of food emulsifiers on bacterial translocation through M-cells and Caco2-cl1 monocultures, cells were pretreated on the apical aspect for 30 min prior to 4 h infection with 0.5 ml DMEM containing 0.0001–0.1% vol/vol of either polysorbate-80 or polysorbate-60.
Tissue specimens from macro- and microscopically normal terminal ileum were obtained from patients (eight women and one man, median age 69 (range 36–91) years) who were undergoing surgery for colonic cancer (N=3) or surveillance colonoscopy for colonic polyps (N=6); The colon cancer patients had no signs of generalised disease and none had received preoperative chemo- or radiotherapy. All patients had given their informed consent.
Bacterial uptake across ileal FAE and VE was performed in Ussing chambers.31 Briefly, tissue mounted in chambers was pre-incubated for 30 min with plantain NSP (5 or 50 mg/ml) or polysorbate-80 (0.01 or 0.1% vol/vol). EGFP-expressing adherent, invasive E coli HM615 was added to the mucosal compartment (1×108 CFU/ml). After 2 h, serosal compartment buffer was sampled and measured at 488 nm in a fluorimeter. Numbers of bacteria translocated to the serosal compartment were enumerated relative to an EGFP-expressing E coli HM615 standard curve, with confirmation by CFU counting. Transepithelial potential difference (PD) and TEER was monitored throughout. Following Ussing experiments, tissue viability was assessed by adding forskolin (10 μM) to the apical chamber, which raises levels of cyclic AMP with resultant active net ion transport in viable tissue (as assessed by an increased short-circuit current). This was followed by histological examination of tissue within each chamber.
Following infection, cell monolayers were fixed in 2% glutaraldehyde and 4% paraformaldehyde in sterile PBS. Cells were washed with PBS (5 min), twice in PBS/0.15 M glycine and then again in PBS alone. Cells were carefully scraped into microfuge tubes containing PBS, centrifuged at 9000 g for 2 min, 2% agarose added, centrifuged again, then placed on ice until set. Samples were trimmed to 1 mm3, incubated in 1% osmium tetroxide for 1 h at room temperature, followed by sequential dehydration in ethanol and acetone, and mounted in Araldite resin. Sections (70 nm) were loaded onto copper grids, stained for 5 min each in Reynold's lead citrate and 5% uranyl acetate, washed in distilled water, air-dried and examined using a FEI 120kV Tecnai G2 Spirit BioTWIN transmission electron microscope (FEI Company; Hillsboro, OR, USA).
N numbers indicate the total number of independent experiments performed, where each experiment was performed using n=3–8 replicates for any individual treatment group, unless otherwise indicated. For the isolated human tissue experiments, N=the number of patients. Independent sample groups were assessed for normality and equality of variances. As appropriate, treatment groups were either analysed using the Mann–Whitney U or, for multiple treatment groups, Kruskal–Wallis analysis of variance (ANOVA) was employed, followed by pair-wise comparisons of treatment means (StatsDirect v2.6.2; Sale, UK). Differences were considered significant when p<0.05.
Successful generation of M-cells was confirmed both structurally and functionally. Around 20–70% of the cells within an ‘M-cell’ monolayer lacked clearly defined microvilli, while the remainder maintained a structure more closely resembling parent Caco2-cl1 cells (figure 1). Preliminary experiments indicated that co-culture of Caco2-cl1 cells with Raji B cells for 6 days resulted in optimal M-cell generation without significant loss of monolayer integrity, as indicated by a maintained level of TEER throughout the co-culture (figure 1). Cell monolayers where the TEER fell below 300 Ω cm2 at any point during the course of culture were discarded.
Translocation of Salmonella typhimurium and S sonnei (figure 1G,H) were both confirmed to be significantly higher (83.3±12.3 and 8.6±1.6-fold increases (mean±SEM); both p<0.01; N=3) through Caco2-cl1-Raji B cell co-cultures when compared to Caco2-cl1 cells alone, indicating successful generation of M-like cells.
Using a representative Crohn's disease mucosa-associated E coli, HM605,6 11 12 translocation across M-cells was first quantifiable within 15 min post-infection, while translocation across Caco2-cl1 monocultures could not be detected until at least 30 min post-infection (figure 2A). All eight Crohn's disease E coli isolates were observed to translocate through M-cells more readily, 15.8-fold median increase (IQR 6.2–32.0; N=8) than through Caco2-cl1 monocultures (figure 2B). Translocation of control patient E coli isolates through M-cells was also significantly greater (6.7-fold; IQR 3.7–21.0; N=5) than that seen through Caco2-cl1 cells. Translocation of the E coli K12, albeit occurring at much lower levels than Crohn's and control patient E coli, was increased 2.3-fold through M-cells (figure 2B), whereas the reference E coli XL-1blue demonstrated minimal ability to translocate via M-cells. Similarly, probiotic E coli Nissle 1917 was translocated less across M-cells than across Caco2-cl1 monolayers (figure 2B).
In all cases, the integrity of cell monolayers was maintained throughout the course of infection as indicated by TEER values >300 Ω cm2. Translocation of bacteria was not dependent on the TEER; there was no observable correlation between high translocation rates, and lower TEER values, for both M-cells and Caco2-cl1 cells when TEER was in excess of 300 Ω cm2 (Supplementary document S2).
TEM studies, using Crohn's E coli HM605, showed the presence of bacteria within M-cells implying that translocation was transcellular and not paracellular (figure 2C). E coli HM605 was therefore used for the investigation of dose-dependent effects of soluble dietary fibre and emulsifiers on translocation across M-cells in vitro.
As per our previous observations in HT29 and I407 cells,6 plantain NSP, at both 5 and 50 mg/ml, inhibited E coli adhesion and invasion to the Caco2-cl1 epithelial cell-line used to generate M-cells (Supplementary document S3).
Plantain NSP was also shown to significantly block translocation of Crohn's disease E coli HM605 through M-cells, both at 5 and 50 mg/mL; both p<0.01 ANOVA (figure 3A). Likewise, broccoli NSP significantly inhibited bacterial translocation across M-cells in a dose-dependent manner, at concentrations of ≥ 0.5 mg/mL (figure 3B). Similar inhibition of translocation of E coli HM605 (albeit at lower bacterial numbers) was seen in Caco2-cl1 monocultures.
Conversely, neither leek NSP (upto 50 mg/mL) nor apple NSP, (upto 5 mg/mL) had any significant effect upon bacterial translocation across M-cells (figure 3C,D). Apple NSP was not tested at 50 mg/ml, as this concentration resulted in gelling of the NSP. At all concentrations tested, soluble fibre preparations had no significant effect upon monolayer TEER. No evidence could be found to suggest that fibres could cross the epithelium and directly inhibit bacterial growth. The converse was in fact the case, with plantain NSP significantly enhancing bacterial growth (in a concentration dependant manner) as much as 14.7(±0.6)-fold at 50 mg/ml (n=4), over a 4.5 h experimental period (inclusive of 30 min pre-treatment), as determined by culture of the apical Transwell compartment medium.
The inhibitory effect of plantain NSP was observed to be independent of Crohn's disease E coli strain; HM580, 67.4±1.7%; HM605, 82.6±7.2%; HM615, 45.3±3.3% and ileal Crohn's isolate LF82, 61.6±13.0% inhibition at 4 h, for 5 mg/ml plantain NSP; all p<0.05) (figure 3E). The low level of M-cell translocation seen with non-pathogenic reference E coli K12 was also inhibited by plantain NSP; 59.0±11.1%, p<0.05. An inhibitory effect of plantain NSP on translocation of E coli across Caco2-cl1 monocultures was also observed (Supplementary document S4).
Permeability to EGFP-expressing Crohn's disease E coli HM615 was increased 2-fold across isolated human FAE mounted in Ussing chambers when compared to VE: Histological assessment verified epithelial type in each chamber (figure 4A,B). Translocation of EGFP-E coli HM615 across FAE was seen to be significantly reduced in the presence of plantain NSP, to 45±7% (at 5 mg/ml) and 27±7% (at 50 mg/ml) of control levels without plantain treatment (100%; 8.91±1.8×105 bacteria/ml/2 h); both p<0.01 ANOVA, N=7 (figure 4C). Similarly, plantain NSP reduced E coli translocation across isolated VE, reaching significance at 50 mg/ml (33±9% reduction) compared to control levels without plantain (100%; 4.37±0.71×105 bacteria/ml/2 h);, p<0.001 ANOVA, N=9 (figure 4D). TEER was maintained throughout all experiments. Numbers of bacteria translocated to the serosal compartment were confirmed by overnight culture (figure 4E).
In vitro modelling of fibre breakdown by mixed faecal bacteria obtained from a healthy volunteer (see methods in Supplementary document S5) suggested that 25.4±8.5% (n=4) of ingested plantain NSP would be fermented to fatty acids in the human colon within 24 h. Assuming passage of 1 litre of fluid daily into the caecum, intake of 10 g fibre/day would produce NSP concentrations of 10 and 7.5 mg/ml in the caecum and rectum respectively. It is of course probable that the latter would also include incompletely degraded fibre components.
The translocation of Crohn's E coli HM605 across M-cells over 4 h was significantly increased (5.3±2.0-fold; mean±SD, N=5) in the presence of 0.1% vol/vol of the permitted food emulsifier polysorbate-80 (figure 5A). A similar action for polysorbate-80 was also observed when using ex vivo human ileal tissue mounted in Ussing chambers. Polysorbate-80, at 0.1% vol/vol, significantly enhanced EGFP-expressing E coli HM615 translocation 2±0.2-fold across human FAE (N=6) relative to untreated control; p<0.01 ANOVA, N=9 (figure 5B).
Furthermore, E coli HM605 translocation across Caco2-cl1 monocultures was greatly increased (59.3±33.2-fold, N=5) by addition of polysorbate-80 into the apical media at a concentration (0.01%) 10-fold lower than that needed to increase translocation across M-cells (figure 5C). A similar but smaller trend of increased translocation of E coli (2.9±1.6-fold) was also observed across isolated VE following pre-treatment with both 0.01% and 0.1% polysorbate-80; N=4 and N=8 respectively (figure 5D).
No disruption to the monolayer integrity, as indicated through maintenance of TEER, was observed with emulsifier concentrations of ≤0.1% vol/vol, whereas in preliminary experiments, emulsifier concentrations of ≥1% did dramatically decrease TEER and significantly reduce bacterial growth. TEER was maintained throughout all Ussing experiments.
For dietary emulsifier polysorbate-60, translocation of E coli across Caco2-cl1 monocultures was also significantly increased (14.2±4.8-fold) in the presence of the highest concentration tested, 0.1% vol/vol (p<0.05; ANOVA, N=5). However, no such increase was observed across M-cells at all concentrations investigated (0.001–0.1% vol/vol) and polysorbate-60 was therefore not studied in the ex vivo model.
This study confirms that Caco2-cl1-derived M-cells can be used to assess translocation of mucosal bacterial isolates and shows the expected, markedly increased, translocation of Salmonella typhimurium and S sonnei in comparison with their translocation through parent Caco2-cl1 monocultures. TEM confirms the M-cell phenotype with a relative lack of apical microvilli. TEER was maintained throughout all experiments and translocation was clearly shown to be transcellular. E coli isolated from Crohn's mucosae translocated more readily through M-cells than non-IBD and other control E coli, in keeping with their adherent, invasive phenotype. In addition, the epithelia-type specificity for Crohn's E coli was verified in studies on human FAE and VE ex vivo.
Soluble plant fibres, particularly those present in plantain and broccoli, are shown to inhibit translocation of Crohn's mucosa-associated E coli isolates across M-cells, at concentrations that should be readily achievable in vivo. This implies that dietary supplementation with such fibres might have a protective effect against Crohn's disease relapse by preventing bacterial invasion of the mucosa. NSP from plantain, as from other plant sources, might also have a conventional prebiotic effect via encouragement of probiotic bacteria that would not be relevant to the effects seen in these in vitro models. We feel that the ability of soluble plant fibres to block epithelial attachment and translocation by bacteria may be at least as important as any prebiotic effect, particularly in the small intestine. It also suggests that further investigation is warranted to assess whether soluble dietary fibre might have a more generalised beneficial effect on intestinal health, including bowel cancer and diarrhoeal disease, as a consequence of this ability to block interaction between intestinal bacteria and the epithelium.
The potential importance of M-cells as a portal for bacterial invasion in Crohn's disease is supported by evidence that the initial aphthoid ulcer lesions of Crohn's tend to occur in the mucosa overlying PP in the distal ileum and lymphoid follicles in the colon.16 32 33 Indeed, ex vivo work conducted with macroscopically normal Crohn's disease FAE biopsies show increased numbers of adherent non-pathogenic E coli compared to controls.34 Chronic stress has been shown in rats to lead to increased passage of E coli K12 across FAE, but not VE.35
The effect of food emulsifiers on E coli translocation provides another potential explanation for the association between the modern ‘Western’ diet and Crohn's pathogenesis. Polysorbate-80 at 0.1% vol/vol, led to 5-fold increased translocation across M-cells and a doubled translocation across human FAE. At the lower concentration of 0.01%, a 59-fold increase in translocation across Caco2-cl1 cells was observed, both without any negative effect on monolayer TEER. Based on the acceptable daily intake of 25 mg/kg polysorbate-80 to body weight,36 this concentration of 0.01% would represent a persistence of 6.7% into the terminal ileum of a typical 60 kg human, assuming 1 litre of intestinal contents per day passing to the caecum. Previous studies in healthy human volunteers have shown 5% urinary excretion of the polyoxyethylene portion of orally ingested polysorbate-80.37 It is not known to what extent the polysorbate ester, which is split by pancreatic lipase, might pass through to the terminal ileum. Polysorbate-80 has been shown to integrate within cell membranes28 resulting in a change of membrane microviscosity.29 It is possible that alterations in the membrane fluidity could alter bacterial adhesion and translocation through epithelial cells. The data presented here indicate that Caco2-cl1 cells are more susceptible to the effects of polysorbate-80 than M-cells, and that both cell types are more susceptible to the effects of polysorbate-80 than polysorbate-60. The increase in bacterial translocation across the parent Caco2-cl1 cells, although less relevant to invasion via PP or lymphoid follicles, might imply a greater risk of bacterial mucosal invasion at other sites. In the small intestine, unlike the colon, the mucus layer is not continuous38 and the epithelium will be relatively exposed to emulsifiers. The effects of emulsifiers may have important implications for treatment of Crohn's disease, particularly in view of the increased permeability that is already known to exist in this condition. Enteral nutritional feeding with elemental or whole protein feed is often used as either primary or adjuvant therapy for Crohn's disease.4 All enteral feeds that are ready mixed as a liquid and contain lipid, contain emulsifers. The emulsifier used will vary from feed to feed. We have previously commented that the varying response to Crohn's disease of different enteral feeds might relate to their emulsifier content39 and are currently exploring the possible epidemiological association between inflammatory bowel disease and emulsifier consumption.
These studies show that different dietary components may have powerful and contrasting effects on bacterial translocation across intestinal M-cells. These effects may be relevant to the role of environmental factors in the pathogenesis of Crohn's disease and suggest possible novel therapeutic approaches.
Adherent, invasive E coli LF82 was a gift from Professor Arlette Darfeuille-Michaud, Université Auvergne Clermont-1, Clermont-Ferrand F-63001, France. The authors are extremely grateful for support from Drs Ian Prior and Connie Muncke of the Electron Microscopy Unit, Biomedical Sciences, University of Liverpool. The authors also wish to thank Mrs Ylva Braaf for skilful technical assistance in the Linköping Ussing laboratory.
Funding: CLR was supported by the Wellcome Trust 4 year PhD programme in Cellular and Molecular Physiology (074949/Z/04/Z). Further support to BJC and JMR was provided by the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Microbial Diseases, Liverpool (01CD1) and the National Association for Colitis & Crohn's disease (M/08/1). Translocation studies using human tissues were funded by a grant to JDS from the Swedish Research Council (VR-M). Other funders: Wellcome Trust; NIHR, MRC, NACC, Swedish Research Council.
Competing interests: JMR is a past/present member of advisory boards for Procter & Gamble, Schering-Plough, Chiesi, Falk and Celltech. With the University of Liverpool and Provexis Plc (UK), JMR holds a patent for use of a soluble fibre preparation as therapy for Crohn's disease. NO'K is an employee of Provexis Plc.
Ethics approval: This study was conducted with the approval of the Regional Human Ethics Committee; Linköping, Sweden.
Contributors: BJC, CLR, JDS and JMR designed the research and obtained funding; CLR, AVK and SHD performed experiments; BJC, CLR, JMR, NO'K, AVK, JDS and SHD performed analysis and interpretation of data; NO'K provided material support; BJC, CLR and JMR wrote the manuscript.
Provenance and peer review: Not commissioned; externally peer reviewed.